close icon

Walgreens: Did the Market Foresee that KKR Offer?

Anyone who’s been in Elliott Wave analysis long enough has noticed how often some external factor “makes the price move” in the direction the analysis had identified much earlier. We’ve seen it happening in crypto, we’ve seen in happening in stock indices. Now, it happened with Walgreens stock.

Walgreens jumped on November 5th after CNBC reported the company was exploring a go-private deal. The rumor turned out to be true on November 11th, when the drug-store chain was officially approached by private equity firm KKR.

Walgreens was down to a multi-year low of $49.03 in late-August, but spiked to $64.50 after the rumor first came out. What is more interesting is the fact that there was a bullish Elliott Wave setup in place two months earlier. Take a look at it below.

Walgreens Stock to Regain its Footing

This chart was published on September 5th in an article titled “Walgreens Stock Can Add Roughly 30%.” It revealed that the decline between $86 and $49 was a complete five-wave impulse pattern. To every Elliott Wave analyst this meant that a move in the opposite direction can be expected.

Elliott Wave Analysis ahead of the Walgreens Buyout Rumor

The anticipated rally had to be of respectable size in relation to the preceding impulse. So, we thought “we can expect a notable recovery to roughly $65 a share for a total gain of nearly 30%.” In addition, there was a strong bullish MACD divergence supporting the positive outlook.

The next chart shows Walgreens stock as it is today, over two months after the September 5th analysis.

Walgreens completes Elliott Wave cycle as KKR prepares a go-private offer

Walgreens stock was at $51.44 when we first spotted the complete five-wave pattern. Precisely two months later, it touched $64.50 for a 25.4% gain. Now, two possibilities exist.

One, KKR takes Walgreens private at a price not much higher than the current market price. And two, the companies fail to reach a deal and Walgreens remains a public entity. That second possibility is probably keeping arbitrageurs up at night.

If a deal is not reached, WBA stock will be at the mercy of pure market forces again. The problem is that with a complete bearish 5-3 wave cycle already in place, another selloff is going to be very likely. In other words, if KKR fails to pull off the largest leveraged buyout in history, Walgreens stock may revisit the sub-$50 area once more…

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Clorox Stock Can Lose 25% if a Recession Hits in 2020

As a consumer products manufacturer Clorox is one of the so-called “defensive” companies, whose sales are generally not dependent on the state of the economy. However, this doesn’t mean Clorox stock cannot fall during a general market decline or a recession. For instance, it lost 57% in the 1999-2000 rout and over 34% during the…

Read More »

Ubiquiti Can Dive in a 50% Elliott Wave Correction

Headquartered in New York, Ubiquiti Inc. is a communication equipment manufacturer with a market cap of ~$13 billion. The stock is up 85% since its late-August low and is now trading in the vicinity of $200 a share. Understandably, such sharp and fast rallies easily attract people’s attention. Extrapolation of the past into the future…

Read More »

Disney Stock Forming a Major Elliott Wave Top

The last time we wrote about Disney stock was on April 17th. The company had just announced its own streaming service, sending the price sharply higher to over $130 a share. The interesting part was not the surge itself, but the fact that the Elliott Wave principle managed to prepare us for it a year…

Read More »

Bristol-Myers Stock Pattern Triggers a 37% Surge

Bristol-Myers Squibb and Celgene are expected to merge into a single company before the end of the year. The deal will create the fifth largest pharmaceutical company in the world with sales of approximately $42 billion in 2019. Bristol-Myers fell sharply after the deal was announced in early-January. In late-April, the stock was still in…

Read More »

Home Capital: Third Wave Lifts Stock 140% in 2019

Home Capital Group is up 17.4% in Toronto today following the company’s third quarter financial report. The mortgage lender beat analysts’ earnings expectations and delivered improvements in other areas, too. In total, HCG is up ~140% in 2019. But things didn’t look so rosy at the beginning of the year. The stock was hovering in…

Read More »

SERV Stock Gave a Warning Before Crashing 40%

The last three weeks have been tough on ServiceMaster shareholders. SERV stock was hovering around $56 a share as October went into its final third. But when the company announced its preliminary Q3 results on October 22nd, all hell broke loose. Apparently, Wall Street didn’t like what it saw, which resulted in a swift and…

Read More »

Expedia Disappointed. Elliott Wave Analysis Did Not

Expedia stock is down 25% today after the company’s Q3 results missed expectations. GAAP EPS fell 57 cents short of analysts’ estimates. The revenue figure was anticipated to be $10 million higher than reported, as well. On top of that, Expedia cut its full-year guidance which annoyed Wall Street even more. That is the official…

Read More »

More analyses